Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
71 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
22 Recruiting Sanitation, Water, and Instruction in Face-washing for Trachoma
Condition: Trachoma
Interventions: Behavioral: Water, sanitation, and hygiene (WASH) intervention;   Behavioral: Standard of care WASH intervention;   Drug: Azithromycin;   Drug: Tetracycline;   Other: Control;   Drug: Albendazole
23 Not yet recruiting HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)
Condition: Dry Eye Disease
Interventions: Drug: SYL1001 ophthalmic solution;   Drug: Vehicle opthalmic solution
24 Recruiting Intense Pulsed Light Study for Dry Eye Disease
Condition: Dry Eyes Chronic
Interventions: Device: Intense Pulsed Light Therapy;   Procedure: Sham Treatment
25 Recruiting Lamelleye vs Comparator for the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Device: Lamelleye Dry Eye Drops;   Device: Optive Plus
26 Recruiting Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Device: NovaTears®;   Device: Hydrabak®
27 Recruiting Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
28 Recruiting Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Tear Deficient Dry Eye Disease.
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
29 Not yet recruiting A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Condition: Dry Eye Disease
Intervention: Drug: ISV 101
30 Recruiting Walnut Shell Glasses Moxibustion for Dry Eye Syndrome
Condition: Dry Eye
Interventions: Procedure: Walnut Shell Glasses Moxibustion;   Drug: Sodium hyaluronate eye drops
31 Recruiting Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)
Condition: Dry Eye
Interventions: Diagnostic Test: Tear Film Imager;   Diagnostic Test: Low Humidity Environmental Exposure Chamber (LH-EEC)
32 Recruiting An 8-week Study to Evaluate Safety and Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients With Dry Eye
Condition: Dry Eye
Interventions: Drug: NGF;   Other: Vehicle
33 Not yet recruiting PILOT STUDY FOR TESTING SAFETY OF REPETITIVE MAGNETIC STIMULATION FOR TREATMENT OF DRY EYE
Condition: Dry Eye
Intervention: Device: repeated magnetic stimulation (RMS) treatment to the eye
34 Not yet recruiting Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity
Condition: Dry Eye
Intervention: Device: Intense Pulse Light Energy delivery (IPL)
35 Recruiting Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
Condition: Dry Eye
Interventions: Drug: Liposic;   Drug: Tears Naturale Forte
36 Not yet recruiting A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye
Condition: Dry Eye
Interventions: Device: CBL-101 Eye Drops;   Device: Vismed® Multi
37 Recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
38 Not yet recruiting Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
Condition: Dry Eye Syndrome
Interventions: Device: intense pulsed light;   Drug: Tobramycin and Dexamethasone Ophthalmic Ointment
39 Recruiting Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye
Condition: Dry Eye Syndromes
Interventions: Device: REMOGEN OMEGA;   Device: Povidone
40 Not yet recruiting A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: Omega 3;   Drug: Optive Advanced;   Drug: Optive

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.